Minerva Investor Alert: Class Action Lawsuit Filed

BOSTON, MA / ACCESSWIRE / January 27, 2021 / Thornton law firm announces that a class action lawsuit has been filed on behalf of investors in Minerva Neurosciences, Inc. (NASDAQ: NERV). Investors who purchased NERV common stock or other securities between May 15, 2017 and November 30, 2020 may contact the Thornton law firm for a copy of the complaint or to discuss the lead plaintiff’s process. Interested investors are invited to visit www.tenlaw.com/cases/Minerva. Investors can email investors@tenlaw.com or call 617-531-3917. Interested Minerva investors have until February 8, 2021 to apply as the lead plaintiff.

More information: www.tenlaw.com/cases/Minerva

In the case, it is alleged that Minerva and his executive made misleading statements to investors and failed to disclose: (i) the truth of the negative feedback from the FDA on the “End of Phase 2” meeting for MIN-101; (ii) the Phase 2b study did not use the commercial formulation of MIN-101 and was conducted outside of the US only; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study unable to provide substantial evidence of efficacy; (iv) It is “highly unlikely” that the Company’s plan to use the combination of Phase 2b and 3 studies will support submission of an NDA. and (v) reliance on these two studies in filing an NDA would create “significant review problems” because the studies were inadequate and not well controlled.

For more information, please visit: www.tenlaw.com/cases/Minerva

The lawsuit asserts violations of the Federal Securities Act. The Private Securities Litigation Reform Act of 1995 allows any investor who purchased the securities in question during the class period to seek appointment as the lead plaintiff in the lawsuit. A lead plaintiff will act on behalf of all other members of the investor class in administering the class action and may select a law firm of their choice to bring the lawsuit. Acting as the lead plaintiff does not affect an investor’s share in a possible recovery. Investors don’t have to be a prime plaintiff to be a member of the class. If investors fail to take action, they can remain an absent class member. Interested Minerva investors have until February 8, 2021 to apply as the lead plaintiff. The class has not yet been certified. Investors will not be represented by a lawyer until certification.

The story goes on

Thornton’s securities attorneys have extensive experience in representing investors in recovering damages caused by violations of securities laws. The company’s attorneys have a proven record of litigating securities cases in courts across the country and collecting losses on behalf of investors. This can be seen as a lawyer promotion in some countries. Past results do not guarantee or forecast a similar result with respect to future matters.


Thornton LLP law firm
1 Lincoln Street
State Street Financial Center
Boston, MA 02111

SOURCE: Thornton LLP law firm

View source version on accesswire.com:

Comments are closed.